Correlation Between Bristol Myers and NV Bekaert

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and NV Bekaert at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and NV Bekaert into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and NV Bekaert SA, you can compare the effects of market volatilities on Bristol Myers and NV Bekaert and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of NV Bekaert. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and NV Bekaert.

Diversification Opportunities for Bristol Myers and NV Bekaert

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and BEKAY is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and NV Bekaert SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NV Bekaert SA and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with NV Bekaert. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NV Bekaert SA has no effect on the direction of Bristol Myers i.e., Bristol Myers and NV Bekaert go up and down completely randomly.

Pair Corralation between Bristol Myers and NV Bekaert

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the NV Bekaert. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 1.8 times less risky than NV Bekaert. The stock trades about -0.02 of its potential returns per unit of risk. The NV Bekaert SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  351.00  in NV Bekaert SA on September 3, 2024 and sell it today you would earn a total of  36.00  from holding NV Bekaert SA or generate 10.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy61.62%
ValuesDaily Returns

Bristol Myers Squibb  vs.  NV Bekaert SA

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
NV Bekaert SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NV Bekaert SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bristol Myers and NV Bekaert Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and NV Bekaert

The main advantage of trading using opposite Bristol Myers and NV Bekaert positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, NV Bekaert can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NV Bekaert will offset losses from the drop in NV Bekaert's long position.
The idea behind Bristol Myers Squibb and NV Bekaert SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities